Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a2a028ae9b4848fc

Jump to content

Ovoferrin

From Wikipedia, the free encyclopedia

Ovoferrin was a dietary supplement originally produced in the United States by A.C. Barnes Company[1] of Philadelphia, Pennsylvania[2] and later by Zonite Products Corporation, which acquired A.C. Barnes Company in 1929.[1] The product grossed approximately $400,000 annually in 1929.[2] Both Ovoferrin and Argyrol continued to be exclusively manufactured by A.C. Barnes Company, which became a subsidiary of Zonite Products Corporation. On January 2, 1946 Ovoferrin and Argyrol were assigned to Erwin, Wasey & Company, a New York based advertising agency.[3]

Chemical composition

[edit]

Ovoferrin was advertised as a supplement for iron and Vitamin B.[4]

Ovoferrin's manufacturer described its makeup as being neutral in reaction. A tablespoon was stated to be equivalent to a single grain of elementary iron. When potassium ferrocyanide is added to Ovorferrin no change is observed. However the addition of hydrochloric acid to Ovoferrin produces a well-known color and precipitate of Prussian blue. This indicates that hydrochloric acid changes Ovoferrin, producing an inorganic iron.[5]

References

[edit]
  1. 1 2 Inquiring Investor, Wall Street Journal, November 29, 1930, pg. 11.
  2. 1 2 Zonite Capital Plan Approved, Wall Street Journal, July 12, 1929, pg. 9.
  3. Advertising News and Notes, New York Times, October 10, 1945, pg. 25.
  4. "Ovoferrin". National Museum of American History. Retrieved 2019-09-01.
  5. American Druggist and Pharmaceutical Record, American Druggist Publishing Company, 1904, pg. 171.